Found 0 matching trials
Developing Self-Management Interventions After HCT
N/AThis is a prospective, longitudinal, observational trial to evaluate qualit...
Location
UF Health Cancer Hospital
Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy
PHASE1Altering the Gut Microbiota of Melanoma Patients Who Failed Immunotherapy U...
Location
Sheba Medical Center
The Association of Microbiota Composition With cGVHD After Allo-HSCT
N/APrevious studies had found that the microbe in intestinal after allogeneic ...
Location
The first Affiliated Hospital of Zhejiang University
The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients.
EARLY_PHASE1Ankylosing spondylitis (AS) patients often have subclinical gut wall inflam...
Location
Hospital District of Helsinki and Uusimaa, Department of Rheumatology
Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients
PHASE2The proposed randomized, open label, with treat as usual control group (sta...
Location
London Health Sciences Centre, University Hospital
Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization
PHASE2Double-blinded, randomised controlled trial to evaluate the clinical effica...
Location
Multiple Locations
Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum
PHASE1Fecal microbiota transplantation (FMT) is the reconstitution of normal flor...
Location
Massachusetts General Hospital
Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis
PHASE2The aim of our study is to investigate the efficacy and safety of fecal mic...
Location
Helsinki University Central Hospital
Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
PHASE1Background:
Chronic granulomatous disease (CGD) weakens the body's defense...
Location
National Institutes of Health Clinical Center
Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis
PHASE1Patients with unexplained atherosclerosis (severe atherosclerosis not expla...
Location
Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute